Health Affairs January 1, 2025
Maryam Mooghali, Osman Moneer, Guneet Janda, Sanket S. Dhruva, Joseph S. Ross, Reshma Ramachandran

Abstract

The Centers for Medicare and Medicaid Services (CMS) coverage with evidence development (CED) program provides coverage for items and services not meeting Medicare’s “reasonable and necessary” standard while requiring participation in clinical studies. As additional evidence is available, CMS may reconsider CED decisions. Of twenty-six items and services in the CED program since its 2005 inception, CMS has reconsidered coverage for ten (38 percent). Of 235 publications that CMS cited as evidence supporting reconsideration, 57 (24...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare
State Policy Levers Can Increase Enrollment In Medicare Savings Programs
ACP expresses support for proposed Medicare $2 Drug List Model
An Introduction to MIPS Basics
How Healthcare Leaders Reacted to the 15 Additional Drugs Selected for Medicare Negotiation Program
Lawmakers, experts weigh in on Medicare Drug Price Negotiation Program

Share This Article